Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

T405, a New Penem, Exhibits In Vivo Efficacy against M. abscessus and Synergy with β-Lactams Imipenem and Cefditoren

Antimicrobial Agents and Chemotherapy(2022)10.1128/aac.00536-22Source: DataRank Database

T405, a New Penem, Exhibits In Vivo Efficacy against M. abscessus and Synergy with β-Lactams Imipenem and Cefditoren is a research paper published in Antimicrobial Agents and Chemotherapy (2022). On theSindex it has a DataRank of 0. It has been cited 18 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access18 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)OA: hybridTopics (31)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Hunter R. Batchelder ORCID,Elizabeth Story‐Roller ORCID,Chandra M. Panthi,Chavis Tabor,Eric L. Nuermberger ORCID

Live enrichment

PubMed:35638855 PMC:PMC9211421

HHS | National Institutes of Health

Grant: AI137329

HHS | National Institutes of Health

Grant: AI155664

NIAID NIH HHS

Grant: R01 AI137329

NIAID NIH HHS

Grant: R01 AI155664

National Institutes of Health

Grant: 5R01AI155664-03

A strategy for new regimens to treat pulmonary Mycobacteroides abscessus infection

National Institutes of Health

Grant: 1R01AI137329-01

Development of novel penems for drug-resistant tuberculosis

hybridLicense: CC BY

publisherhttps://journals.asm.org/doi/pdf/10.1128/aac.00536-22

Unpaywallhttps://doi.org/10.1128/aac.00536-22

Europe_PMChttps://europepmc.org/articles/PMC9211421

Europe_PMChttps://europepmc.org/articles/PMC9211421?pdf=render

https://pubmed.ncbi.nlm.nih.gov/35638855

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

AnimalsHumansMicebeta-LactamsImipenemCephalosporinsAnti-Bacterial AgentsMicrobial Sensitivity TestsMycobacterium Infections, NontuberculousMeropenem

Keywords

efficacyMycobacterium AbscessusΒ-lactamDual Β-lactamPenemMycobacteroides AbscessusT405Mycobacterium Infections, NontuberculousMeropenemMicrobial Sensitivity Testsbeta-LactamsAnti-Bacterial AgentsCephalosporinsImipenemMiceAnimalsHumansExperimental Therapeutics

Sustainable Development Goals

SDG 3: 3. Good health